“…Additionally, aptamers are capable of retaining their reactivity under a wide range of environmental conditions (Famulok et al, 2007; Iliuk et al, 2011). Recently, various high throughput SELEX technologies have been investigated for development of aptamers against mycotoxins such as Aflatoxins (AFB1, AFB2, and AFM1), Fumonisin B1 (FB1), Zearalenone (ZEA), T2 toxin and Ochratoxin A (OTA; Le et al, 2010; McKeague et al, 2010, 2014; Chen et al, 2013, 2014; Ma et al, 2014, 2015; Malhotra et al, 2014). In most of these reports, mycotoxins are coupled to magnetic nanoparticles, sepharose, agarose based resin, or streptavidin beads prior to selection and screening of aptamers.…”